2013 Press Releases
Depomed To Present At UBS Global Healthcare Conference
Depomed Reports First Quarter 2013 Financial Results
Depomed To Report First Quarter Fiscal Year 2013 Financial Results On Wednesday, May 8, 2013
Depomed To Present At Roth Capital Partners 25th Annual Growth Stock Conference
Trading of Depomed Common Stock Halted
Depomed Provides Update on SEFELSA™ FDA Advisory Committee
Depomed To Present At Cowen and Company Health Care Conference
Depomed Reports Fourth Quarter and Full Year 2012 Financial Results
Depomed To Report Fourth Quarter Fiscal Year 2012 Financial Results On Wednesday, February 20, 2013
Depomed Announces Appointment of Vicente J. Anido, Jr., Ph.D. to Board of Directors, and Retirement of Directors Julian N. Stern and Craig R. Smith, M.D.
DEPO (Common Stock)
+ 0.10 (1.73%)
Data as of 05/24/13 4:00 p.m. ET
Minimum 20 minute delay
Powered By EDGAR Online, Inc.
financial tear sheet
Board of Directors
Webcast and Presentations
A Growing Specialty Pharmaceutical Company
© Depomed All rights reserved
Hane Chow Inc.